Pugliese D - Search Results

1

Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology.

Macaluso FS, Orlando A, Papi C, Festa S, Pugliese D, Bonovas S, Pansieri C, Piovani D, Fiorino G, Fantini MC, Caprioli F, Daperno M, Armuzzi A; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD); Working panel; Review panel. Macaluso FS, et al. Among authors: pugliese d. Dig Liver Dis. 2022 Apr;54(4):440-451. doi: 10.1016/j.dld.2022.01.127. Epub 2022 Feb 17. Dig Liver Dis. 2022. PMID: 35184989 Free article.

2

New biological agents for the treatment of the "high risk" IBD patients.

Guidi L, Marzo M, Felice C, Mocci G, Sparano L, Pugliese D, De Vitis I, Papa A, Armuzzi A. Guidi L, et al. Among authors: pugliese d. Eur Rev Med Pharmacol Sci. 2010 Apr;14(4):342-6. Eur Rev Med Pharmacol Sci. 2010. PMID: 20496545 Review.

3

IBD: Adalimumab for ulcerative colitis— is the glass half empty or half full?

Armuzzi A, Pugliese D. Armuzzi A, et al. Among authors: pugliese d. Nat Rev Gastroenterol Hepatol. 2011 May;8(5):249-51. doi: 10.1038/nrgastro.2011.48. Nat Rev Gastroenterol Hepatol. 2011. PMID: 21423259

4

Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience.

Rizzo G, Armuzzi A, Pugliese D, Verbo A, Papa A, Mattana C, Rapaccini GL, Guidi L, Coco C. Rizzo G, et al. Among authors: pugliese d. Int J Colorectal Dis. 2011 Nov;26(11):1435-44. doi: 10.1007/s00384-011-1236-2. Epub 2011 May 19. Int J Colorectal Dis. 2011. PMID: 21594668

5

Update on the management of inflammatory bowel disease: specific role of adalimumab.

Guidi L, Pugliese D, Armuzzi A. Guidi L, et al. Among authors: pugliese d. Clin Exp Gastroenterol. 2011;4:163-72. doi: 10.2147/CEG.S14558. Epub 2011 Jul 15. Clin Exp Gastroenterol. 2011. PMID: 21904462 Free PMC article.

6

Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.

Papa A, Felice C, Marzo M, Andrisani G, Armuzzi A, Covino M, Mocci G, Pugliese D, De Vitis I, Gasbarrini A, Rapaccini GL, Guidi L. Papa A, et al. Among authors: pugliese d. J Crohns Colitis. 2013 Mar;7(2):113-9. doi: 10.1016/j.crohns.2012.03.001. Epub 2012 Mar 30. J Crohns Colitis. 2013. PMID: 22464811

7

Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission.

Armuzzi A, Pugliese D, Danese S, Rizzo G, Felice C, Marzo M, Andrisani G, Fiorino G, Sociale O, Papa A, De Vitis I, Rapaccini GL, Guidi L. Armuzzi A, et al. Among authors: pugliese d. Inflamm Bowel Dis. 2013 Apr;19(5):1065-72. doi: 10.1097/MIB.0b013e3182802909. Inflamm Bowel Dis. 2013. PMID: 23448790

8

Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients.

Andrisani G, Armuzzi A, Papa A, Marzo M, Felice C, Pugliese D, De Vitis I, Rapaccini GL, Guidi L. Andrisani G, et al. Among authors: pugliese d. J Gastrointestin Liver Dis. 2013 Mar;22(1):21-5. J Gastrointestin Liver Dis. 2013. PMID: 23539386 Free article.

9

Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab.

Armuzzi A, Pugliese D, Nardone OM, Guidi L. Armuzzi A, et al. Among authors: pugliese d. Drug Des Devel Ther. 2013 Apr 8;7:289-96. doi: 10.2147/DDDT.S33197. Print 2013. Drug Des Devel Ther. 2013. PMID: 23630414 Free PMC article. Review.

10

Adalimumab in active ulcerative colitis: a "real-life" observational study.

Italian Group for the Study of Inflammatory Bowel Disease; Armuzzi A, Biancone L, Daperno M, Coli A, Pugliese D, Annese V, Aratari A, Ardizzone S, Balestrieri P, Bossa F, Cappello M, Castiglione F, Cicala M, Danese S, D'Incà R, Dulbecco P, Feliciangeli G, Fries W, Genise S, Gionchetti P, Gozzi S, Kohn A, Lorenzetti R, Milla M, Onali S, Orlando A, Papparella LG, Renna S, Ricci C, Rizzello F, Sostegni R, Guidi L, Papi C. Italian Group for the Study of Inflammatory Bowel Disease, et al. Among authors: d inca r, pugliese d. Dig Liver Dis. 2013 Sep;45(9):738-43. doi: 10.1016/j.dld.2013.03.018. Epub 2013 May 15. Dig Liver Dis. 2013. PMID: 23683530 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

247 results

Search Page